Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iryna Voloshyna

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Cellular Immunology|March 9, 2026
Mechanisms and Therapeutic Strategies to Overcome Immune Checkpoint Inhibitor Resistance in Melanoma, Head and Neck, and Triple-Negative Breast CancersIryna Voloshyna, Apoorvi Tyagi, Stanzin Idga, et al.
Research Square|July 9, 2025
SARS-CoV-2 vaccination unmasks distinct immune dysfunctions across lymphoma subtypes and therapiesYogambigai Velmurugu, Anna Halling Folkmar Rahimic, Ryan Curtin, et al.
Journal of Translational Medicine|July 24, 2019
Cholesterol efflux alterations in adolescent obesity: role of adipose-derived extracellular vesical microRNAsMatthew D Barberio, Lora J Kasselman, Martin P Playford, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Autoantibodies Drive Fcγ Receptor-Dependent Colon Inflammation During Immune Checkpoint BlockadeIryna Voloshyna, Yury Patskovsky, Sabina Sandigursky, et al.
Annals of Clinical and Translational Neurology|September 27, 2022
Hybrid and vaccine-induced immunity against SAR-CoV-2 in MS patients on different disease-modifying therapiesIlya Kister, Ryan Curtin, Jinglan Pei, et al.
Annals of Neurology|March 15, 2022
Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational StudyIlya Kister, Yury Patskovsky, Ryan Curtin, et al.
Nature Medicine|June 5, 2025
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanomaKelsey R Monson, Robert Ferguson, Joanna E Handzlik, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Cellular Immunology|March 9, 2026
Mechanisms and Therapeutic Strategies to Overcome Immune Checkpoint Inhibitor Resistance in Melanoma, Head and Neck, and Triple-Negative Breast CancersIryna Voloshyna, Apoorvi Tyagi, Stanzin Idga, et al.
Research Square|July 9, 2025
SARS-CoV-2 vaccination unmasks distinct immune dysfunctions across lymphoma subtypes and therapiesYogambigai Velmurugu, Anna Halling Folkmar Rahimic, Ryan Curtin, et al.
Journal of Translational Medicine|July 24, 2019
Cholesterol efflux alterations in adolescent obesity: role of adipose-derived extracellular vesical microRNAsMatthew D Barberio, Lora J Kasselman, Martin P Playford, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Autoantibodies Drive Fcγ Receptor-Dependent Colon Inflammation During Immune Checkpoint BlockadeIryna Voloshyna, Yury Patskovsky, Sabina Sandigursky, et al.
Annals of Clinical and Translational Neurology|September 27, 2022
Hybrid and vaccine-induced immunity against SAR-CoV-2 in MS patients on different disease-modifying therapiesIlya Kister, Ryan Curtin, Jinglan Pei, et al.
Annals of Neurology|March 15, 2022
Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational StudyIlya Kister, Yury Patskovsky, Ryan Curtin, et al.
Nature Medicine|June 5, 2025
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanomaKelsey R Monson, Robert Ferguson, Joanna E Handzlik, et al.
Pageof 3